Whole Tumor Cell Vaccine for Cancer

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Whole Tumor Cell Vaccine for Cancer Publisher

Razi S^{1, 2} ; Keshavarzfathi M^{1, 3, 4}

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2018

Abstract

Cancer vaccines, which are a type of immunotherapeutic agents, have been widely studied for prevention and treatment of tumors. Therapeutic cancer vaccines improve patient's immune response against tumor cells. One of the several types of cancer vaccines is whole tumor cell vaccine. Whole tumor cell vaccines, which consist of allogeneic or autologous tumor cells or tumor cell lines, contain a large variety of characterized and uncharacterized tumor-associated antigens that could activate antitumor immune reactions. There are several methods for preparation of these vaccines such as tumor cell lysates, tumor-derived exosomes, and irradiated gene-modified tumor cell lines. This chapter will briefly describe the clinical trials, advantages and disadvantages of these vaccines and will discuss some ways that can help to optimize these vaccines. © 2019 Nima Rezaei and Mahsa Keshavarz-Fathi Published by Elsevier Ltd All rights reserved.

Related Docs

View other Related Docs

1. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

2. Tumor-Derived Exosomes: The Next Generation of Promising Cell-Free Vaccines in Cancer Immunotherapy, OncoImmunology (2020)

3. Immune Cell Vaccine For Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (10)

Somayeh Ebrahimi Barough (1)

Other Related Docs

4. Immune Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

5. Development and Clinical Application of Tumor-Derived Exosomes in Patients With Cancer, Current Stem Cell Research and Therapy (2022)

6. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

7. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

8. Candidate Cancers for Vaccination, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

9. Candidate Cancers for Vaccination, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

10. Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy, Molecular Cancer (2022)

11. Texosome-Based Drug Delivery System for Cancer Therapy: From Past to Present, Cancer Biology and Medicine (2015)

12. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)

13. New Approaches in Cancer Immunotherapy: Review Article, Tehran University Medical Journal (2018)

14. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)

15. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy, Frontiers in Immunology (2020)

16. The Roles of Tumor-Derived Exosomes in Altered Differentiation, Maturation and Function of Dendritic Cells, Molecular Cancer (2021)

17. The Role of Extracellular Vesicles in Immune Cell Exhaustion and Resistance to Immunotherapy, Expert Opinion on Investigational Drugs (2024)

18. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

19. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)

20. Tumor-Derived Exosomal Micrornas and Proteins As Modulators of Macrophage Function, Journal of Cellular Physiology (2019)

Style	Citing Format
MLA	Razi S, Keshavarzfathi M. "Whole Tumor Cell Vaccine for Cancer." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, vol. , no. , 2018, pp. 91-99.
APA	Razi S, Keshavarzfathi M (2018). Whole Tumor Cell Vaccine for Cancer. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), 91-99.
Chicago	Razi S, Keshavarzfathi M. "Whole Tumor Cell Vaccine for Cancer." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives , no. (2018): 91-99.
Harvard	Razi S, Keshavarzfathi M (2018) 'Whole Tumor Cell Vaccine for Cancer', Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), pp. 91-99.
Vancouver	Razi S, Keshavarzfathi M. Whole Tumor Cell Vaccine for Cancer. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. 2018;():91-99.
BibTex	@article{ author = {Razi S and Keshavarzfathi M}, title = {Whole Tumor Cell Vaccine for Cancer}, journal = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, volume = {}, number = {}, pages = {91-99}, year = {2018} }
RIS	TY - JOUR AU - Razi S AU - Keshavarzfathi M TI - Whole Tumor Cell Vaccine for Cancer JO - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives VL - IS - SP - 91 EP - 99 PY - 2018 ER -

Science Communicator Platform

Authors

Abstract